Mechanobiology of tumor invasion: Engineering meets oncology

Critical Reviews in Oncology/Hematology

Volumn 83, Issue 2, 2012, Pages 170-183

  Carey, Shawn P ^a   D'Alfonso, Timothy M ^b   Shin, Sandra J ^b   Reinhart King, Cynthia A ^a  

^a School of Chemical and Molecular Engineering   (United States)

^b NEW YORK PRESBYTERIAN HOSPITAL   (United States)

Author keywords

Breast cancer; Cell forces; Mechanobiology; Pathology; Tumor invasion

Indexed keywords

BASEMENT MEMBRANE; BIOLOGY; BREAST CANCER; CANCER INVASION; CARCINOGENESIS; CELL ADHESION; CELL CONTRACTILITY; CELL DEFORMABILITY; CELL MECHANICS; CELL PROTRUSION; CELL STRUCTURE; CELLULAR PARAMETERS; ENGINEERING; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MAMMARY GLAND; MECHANOBIOLOGY; METASTASIS; PHENOTYPE; REVIEW; STROMA; TUMOR STROMA;

ANIMALS; BIOPHYSICAL PHENOMENA; BREAST; BREAST NEOPLASMS; FEMALE; HUMANS; NEOPLASM INVASIVENESS; NEOPLASMS;

EID: 84864041043     PISSN: 10408428     EISSN: 18790461     Source Type: Journal    
DOI: 10.1016/j.critrevonc.2011.11.005     Document Type: Review

References (190)

1. Santini M.T., Rainaldi G., Indovina P.L. Apoptosis, cell adhesion and the extracellular matrix in the three-dimensional growth of multicellular tumor spheroids. Crit Rev Oncol Hemat 2000, 36:75-87.
2. Griffith L.G. Tissue engineering-current challenges and expanding opportunities. Science 2002, 295:1009-1014.
3. Hutmacher D., Horch R., Loessner D., Rizzi S., Sieh S., Reichert J., et al. Translating tissue engineering technology platforms into cancer research. J Cell Mol Med 2009, 13:1417-1427.
4. Armitage P., Doll R. The age distribution of cancer and a multi-stage theory of carcinogenesis. Brit J Cancer 2004, 91:1983-1989.
5. Gatenby R.A., Gawlinski E.T. A reaction-diffusion model of cancer invasion. Cancer Res 1996, 56:5745-5753.
6. Stokes C.L., Lauffenburger D.A. Analysis of the roles of microvessel endothelial cell random motility and chemotaxis in angiogenesis. J Theor Biol 1991, 152:377-403.
7. Byrne H.M. Dissecting cancer through mathematics: from the cell to the animal model. Nat Rev Cancer 2010, 10:221-230.
8. Tracqui P. Biophysical models of tumour growth. Rep Prog Phys 2009, 72:056701.
9. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell 2000, 100:57-70.
10. Ray M.R., Jablons D.M. Hallmarks of metastasis. Lung cancer metastasis 2009, 29-46. Springer, New York, NY. V. Keshamouni, D. Arenberg, G. Kalemkerian (Eds.).
11. Paszek M.J., Zahir N., Johnson K.R., Lakins J.N., Rozenberg G.I., Gefen A., et al. Tensional homeostasis and the malignant phenotype. Cancer Cell 2005, 8:241-254.
12. Yamaguchi H., Condeelis J. Regulation of the actin cytoskeleton in cancer cell migration and invasion. Biochim Biophys Acta 2007, 1773:642-652.
13. Jaalouk D.E., Lammerding J. Mechanotransduction gone awry. Nat Rev Mol Cell Biol 2009, 10:63-73.
14. DuFort C.C., Paszek M.J., Weaver V.M. Balancing forces: architectural control of mechanotransduction. Nat Rev Mol Cell Biol 2011, 12:308-319.
15. Kostic A., Lynch C.D., Sheetz M.P. Differential matrix rigidity response in breast cancer cell lines correlates with the tissue tropism. PloS One 2009, 4:e6361.
16. Liotta L.A., Stetler-Stevenson W.G. Tumor invasion and metastasis: an imbalance of positive and negative regulation. Cancer Res 1991, 51:5054s-5059s.
17. Rosen P.P. Rosen's breast pathology 2001, Lippincott Williams and Wilkins, Philadelphia.
18. Jones J.L., Shaw J.A., Pringle J.H., Walker R.A. Primary breast myoepithelial cells exert an invasion-suppressor effect on breast cancer cells via paracrine down-regulation of MMP expression in fibroblasts and tumour cells. J Pathol 2003, 201:562-572.
19. Adriance M.C., Inman J.L., Petersen O.W., Bissell M.J. Myoepithelial cells: good fences make good neighbors. Breast Cancer Res 2005, 7:190-197.
20. Lohi J. Laminin-5 in the progression of carcinomas. Int J Cancer 2001, 94:763-767.
21. Fu H.L., Moss J., Shore I., Slade M.J., Coombes R.C. Ultrastructural localization of laminin and type IV collagen in normal human breast. Ultrastruct Pathol 2002, 26:77-80.
22. Man Y.-G., Tai L., Barner R., Vang R., Saenger J.S., Shekitka K.M., et al. Cell clusters overlying focally disrupted mammary myoepithelial cell layers and adjacent cells within the same duct display different immunohistochemical and genetic features: implications for tumor progression and invasion. Breast Cancer Res 2003, 5:R231-R241.
23. Chang H.Y., Chi J.-T., Dudoit S., Bondre C., van de Rijn M., Botstein D., et al. Diversity, topographic differentiation, and positional memory in human fibroblasts. Proc Natl Acad Sci USA 2002, 99:12877-12882.
24. Kalluri R., Zeisberg M. Fibroblasts in cancer. Nat Rev Cancer 2006, 6:392-401.
25. Rønnov-Jessen L., Petersen O.W., Bissell M.J. Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction. Physiol Rev 1996, 76:69-125.
26. Wiseman B.S., Werb Z. Stromal effects on mammary gland development and breast cancer. Science 2002, 296:1046-1049.
27. Bissell M.J., Rizki A., Mian I.S. Tissue architecture: the ultimate regulator of breast epithelial function. Curr Opin Cell Biol 2003, 15:753-762.
28. Wang W., Goswami S., Lapidus K., Wells A.L., Wyckoff J.B., Sahai E., et al. Identification and testing of a gene expression signature of invasive carcinoma cells within primary mammary tumors. Cancer Res 2004, 64:8585-8594.
29. Liotta L.A., Tryggvason K., Garbisa S., Hart I., Foltz C.M., Shafie S. Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature 1980, 284:67-68.
30. Gusterson B.A., Warburton M.J., Mitchell D., Ellison M., Neville A.M., Rudland P.S. Distribution of myoepithelial cells and basement membrane proteins in the normal breast and in benign and malignant breast diseases. Cancer Res 1982, 42:4763-4770.
31. Lerwill M.F. Current practical applications of diagnostic immunohistochemistry in breast pathology. Am J Surg Pathol 2004, 28:1076-1091.
32. Schnitt S.J. The transition from ductal carcinoma in situ to invasive breast cancer: the other side of the coin. Breast Cancer Res 2009, 11:101.
33. Burstein H., Polyak K., Wong J., Lester S., Kaelin C. Ductal carcinoma in situ of the breast. N Engl J Med 2004, 350:1430-1441.
34. Hu M., Yao J., Carroll D.K., Weremowicz S., Chen H., Carrasco D., et al. Regulation of in situ to invasive breast carcinoma transition. Cancer Cell 2008, 13:394-406.
35. Mueller M.M., Fusenig N.E. Friends or foes-bipolar effects of the tumour stroma in cancer. Nat Rev Cancer 2004, 4:839-849.
36. Provenzano P.P., Eliceiri K.W., Campbell J.M., Inman D.R., White J.G., Keely P.J. Collagen reorganization at the tumor-stromal interface facilitates local invasion. BMC Med 2006, 4(38).
37. Dvorak H.F., Weaver V.M., Tlsty T.D., Bergers G. Tumor microenvironment and progression. J Surg Oncol 2011, 103:468-474.
38. Kumar V., Abbas A., Fausto N., Aster J. Robbins and Contran pathologic basis of disease 2010, Elsevier Saunders, Philadelphia. 8th ed.
39. Shao Z.M., Nguyen M., Barsky S.H. Human breast carcinoma desmoplasia is PDGF initiated. Oncogene 2000, 19:4337-4345.
40. Iacobuzio-Donahue C.A., Argani P., Hempen P.M., Jones J., Kern S.E. The desmoplastic response to infiltrating breast carcinoma: gene expression at the site of primary invasion and implications for comparisons between tumor types. Cancer Res 2002, 62:5351-5357.
41. Kawashiri S., Tanaka A., Noguchi N. Significance of stromal desmoplasia and myofibroblast appearance at the invasive front in squamous cell carcinoma of the oral cavity. Head Neck 2009, 31:1346-1353.
42. Tamimi S.O., Ahmed A. Stromal changes in invasive breast carcinoma: an ultrastructural study. J Pathol 1987, 153:163-170.
43. De Wever O., Demetter P., Mareel M., Bracke M. Stromal myofibroblasts are drivers of invasive cancer growth. Int J Cancer 2008, 123:2229-2238.
44. Bhowmick N.A., Chytil A., Plieth D., Gorska A.E., Dumont N., Shappell S., et al. TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia. Science 2004, 303:848-851.
45. Goetz J.G., Minguet S., Navarro-Lérida I., Lazcano J.J., Samaniego R., Calvo E., et al. Biomechanical remodeling of the microenvironment by stromal caveolin-1 favors tumor invasion and metastasis. Cell 2011, 146:148-163.
46. Wipff P.-J., Rifkin D.B., Meister J.-J., Hinz B. Myofibroblast contraction activates latent TGF-beta1 from the extracellular matrix. J Cell Biol 2007, 179:1311-1323.
47. Pupa S.M., Ménard S., Forti S., Tagliabue E. New insights into the role of extracellular matrix during tumor onset and progression. J Cell Physiol 2002, 192:259-267.
48. Calorini L., Bianchini F. Environmental control of invasiveness and metastatic dissemination of tumor cells: the role of tumor cell-host cell interactions. Cell Commun Signal 2010, 8(24).
49. Calvo F., Sahai E. Cell communication networks in cancer invasion. Curr Opin Cell Biol 2011, 23:1-9.
50. Wyckoff J., Wang W., Lin E.Y., Wang Y., Pixley F., Stanley E.R., et al. A paracrine loop between tumor cells and macrophages is required for tumor cell migration in mammary tumors. Cancer Res 2004, 64:7022-7029.
51. Goswami S., Sahai E., Wyckoff J.B., Cammer M., Cox D., Pixley F.J., et al. Macrophages promote the invasion of breast carcinoma cells via a colony-stimulating factor-1/epidermal growth factor paracrine loop. Cancer Res 2005, 65:5278-5283.
52. Khalifeh I.M., Albarracin C., Diaz L.K., Symmans F.W., Edgerton M.E., Hwang R.F., et al. Clinical, histopathologic, and immunohistopathologic features of microglandular adenosis and transition into in situ and invasive carcinoma. Am J Surg Pathol 2008, 32:544-552.
53. Collins L.C., Carlo V.P., Hwang H., Barry T.S., Gown A.M., Schnitt S.J. Intracystic papillary carcinomas of the breast: a reevaluation using a panel of myoepithelial cell markers. Am J Surg Pathol 2006, 30:1002-1007.
54. Tamimi R.M., Baer H.J., Marotti J., Galan M., Galaburda L., Fu Y., et al. Comparison of molecular phenotypes of ductal carcinoma in situ and invasive breast cancer. Breast Cancer Res 2008, 10:R67.
55. Wiechmann L., Kuerer H.M. The molecular journey from ductal carcinoma in situ to invasive breast cancer. Cancer 2008, 112:2130-2142.
56. Leong A.S.-Y., Zhuang Z. The changing role of pathology in breast cancer diagnosis and treatment. Pathobiology 2011, 78:99-114.
57. Makale M. Cellular mechanobiology and cancer metastasis. Birth Defects Res C 2007, 81:329-343.
58. Thiery J.P. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2002, 2:442-454.
59. Tarin D., Thompson E.W., Newgreen D.F. The fallacy of epithelial mesenchymal transition in neoplasia. Cancer Res 2005, 65:5996-6000.
60. Christofori G. New signals from the invasive front. Nature 2006, 441:444-450.
61. Lee J.M., Dedhar S., Kalluri R., Thompson E.W. The epithelial-mesenchymal transition: new insights in signaling, development, and disease. J Cell Biol 2006, 172:973-981.
62. Klymkowsky M.W., Savagner P. Epithelial-mesenchymal transition: a cancer researcher's conceptual friend and foe. Am J Pathol 2009, 174:1588-1593.
63. Thomson S., Petti F., Sujka-Kwok I., Mercado P., Bean J., Monaghan M., et al. A systems view of epithelial-mesenchymal transition signaling states. Clin Exp Metastasis 2011, 28:137-155.
64. Friedl P., Wolf K. Tumour-cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer 2003, 3:362-374.
65. Friedl P., Wolf K. Plasticity of cell migration: a multiscale tuning model. J Cell Biol 2010, 188:11-19.
66. Yang J., Mani S.A., Donaher J.L., Ramaswamy S., Itzykson R.A., Come C., et al. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 2004, 117:927-939.
67. Nelson C.M., Khauv D., Bissell M.J., Radisky D.C. Change in cell shape is required for MMP-induced EMT of mammary epithelial cells. J Cell Biochem 2008, 105:25-33.
68. Gomez E.W., Chen Q.K., Gjorevski N., Nelson C.M. Tissue geometry patterns epithelial-mesenchymal transition via intercellular mechanotransduction. J Cell Biochem 2010, 110:44-51.
69. Spaderna S., Schmalhofer O., Hlubek F., Berx G., Eger A., Merkel S., et al. A transient, EMT-linked loss of basement membranes indicates metastasis and poor survival in colorectal cancer. Gastroenterology 2006, 131:830-840.
70. Ryan M.C., Lee K., Miyashita Y., Carter W.G. Targeted disruption of the LAMA3 gene in mice reveals abnormalities in survival and late stage differentiation of epithelial cells. J Cell Biol 1999, 145:1309-1323.
71. Coopman P.J., Do M.T.H., Thompson E.W., Mueller S.C. Phagocytosis of cross-linked gelatin matrix by human breast carcinoma cells correlates with their invasive capacity. Clin Cancer Res 1998, 4:507-515.
72. Chen W.-T. Proteolytic activity of specialized surface protrusions formed at rosette contact sites of transformed cells. J Exp Zool 1989, 251:167-185.
73. Kelly T., Yan Y., Osborne R.L., Athota A.B., Rozypal T.L., Colclasure J.C., et al. Proteolysis of extracellular matrix by invadopodia facilitates human breast cancer cell invasion and is mediated by matrix metalloproteinases. Clin Exp Metastasis 1998, 16:501-512.
74. Wang W., Wyckoff J.B., Frohlich V.C., Oleynikov Y., Hu S., Zavadil J., et al. Single cell behavior in metastatic primary mammary tumors correlated with gene expression patterns revealed by molecular profiling. Cancer Res 2002, 62:6278-6288.
75. Yamaguchi H., Lorenz M., Kempiak S., Sarmiento C., Coniglio S., Symons M., et al. Molecular mechanisms of invadopodium formation: the role of the N-WASP-Arp2/3 complex pathway and cofilin. J Cell Biol 2005, 168:441-452.
76. Yamaguchi H., Wyckoff J., Condeelis J. Cell migration in tumors. Curr Opin Cell Biol 2005, 17:559-564.
77. Weaver A.M. Invadopodia: specialized cell structures for cancer invasion. Clin Exp Metastasis 2006, 23:97-105.
78. Stylli S.S., Kaye A.H., Lock P. Invadopodia: at the cutting edge of tumour invasion. J Clin Neurosci 2008, 15:725-737.
79. Alexander N.R., Branch K.M., Parekh A., Clark E.S., Iwueke I.C., Guelcher S.A., et al. Extracellular matrix rigidity promotes invadopodia activity. Curr Biol 2008, 18:1295-1299.
80. Provenzano P.P., Inman D.R., Eliceiri K.W., Knittel J.G., Yan L., Rueden C.T., et al. Collagen density promotes mammary tumor initiation and progression. BMC Med 2008, 6(11).
81. Schedin P., Keely P.J. Mammary gland ECM remodeling, stiffness, and mechanosignaling in normal development and tumor progression. Cold Spring Harb Perspect Biol 2010, 3:a003228.
82. Oser M., Eddy R., Condeelis J. Actin-based motile processes in tumor cell invasion. Actin-based motility 2010, 125-164. Springer, Netherlands, Dordrecht. M.-F. Carlier (Ed.).
83. Fraley S.I., Feng Y., Krishnamurthy R., Kim D.-H., Celedon A., Longmore G.D., et al. A distinctive role for focal adhesion proteins in three-dimensional cell motility. Nat Cell Biol 2010, 12:598-604.
84. Dikovsky D., Bianco-Peled H., Seliktar D. Defining the role of matrix compliance and proteolysis in three-dimensional cell spreading and remodeling. Biophys J 2008, 94:2914-2925.
85. Kikuchi K., Takahashi K. WAVE2- and microtubule-dependent formation of long protrusions and invasion of cancer cells cultured on three-dimensional extracellular matrices. Cancer Sci 2008, 99:2252-2259.
86. Schoumacher M., Goldman R.D., Louvard D., Vignjevic D.M. Actin, microtubules, and vimentin intermediate filaments cooperate for elongation of invadopodia. J Cell Biol 2010, 189:541-556.
87. Hall A. Rho GTPases and the actin cytoskeleton. Science 1998, 279:509-514.
88. Olson M.F., Sahai E. The actin cytoskeleton in cancer cell motility. Clin Exp Metastasis 2009, 26:273-287.
89. Parri M., Chiarugi P. Rac and Rho GTPases in cancer cell motility control. Cell Commun Signal 2010, 8(23).
90. Nakahara H., Otani T., Sasaki T., Miura Y., Takai Y., Kogo M. Involvement of Cdc42 and Rac small G proteins in invadopodia formation of RPMI7951 cells. Genes Cells 2003, 8:1019-1027.
91. Ada-Nguema A.S., Xenias H., Hofman J.M., Wiggins C.H., Sheetz M.P., Keely P.J. The small GTPase R-Ras regulates organization of actin and drives membrane protrusions through the activity of PLC-epsilon. J Cell Sci 2006, 119:1307-1319.
92. Sanz-Moreno V., Gadea G., Ahn J., Paterson H., Marra P., Pinner S., et al. Rac activation and inactivation control plasticity of tumor cell movement. Cell 2008, 135:510-523.
93. Yamazaki D., Kurisu S., Takenawa T. Involvement of Rac and Rho signaling in cancer cell motility in 3D substrates. Oncogene 2009, 28:1570-1583.
94. Cai Y., Biais N., Giannone G., Tanase M., Jiang G., Hofman J.M., et al. Nonmuscle myosin IIA-dependent force inhibits cell spreading and drives F-actin flow. Biophys J 2006, 91:3907-3920.
95. Shankar J., Messenberg A., Chan J., Underhill T.M., Foster L.J., Nabi I.R. Pseudopodial actin dynamics control epithelial-mesenchymal transition in metastatic cancer cells. Cancer Res 2010, 70:3780-3790.
96. Vial E., Sahai E., Marshall C.J. ERK-MAPK signaling coordinately regulates activity of Rac1 and RhoA for tumor cell motility. Cancer Cell 2003, 4:67-79.
97. Geiger B., Bershadsky A., Pankov R., Yamada K.M. Transmembrane extracellular matrix-cytoskeleton crosstalk. Nat Rev Mol Cell Biol 2001, 2:793-805.
98. Mercurio A.M., Rabinovitz I. Towards a mechanistic understanding of tumor invasion-lessons from the alpha6/beta4 integrin. Semin Cancer Biol 2001, 11:129-141.
99. Hood J.D., Cheresh D.A. Role of integrins in cell invasion and migration. Nat Rev Cancer 2002, 2:91-100.
100. Guo W., Giancotti F.G. Integrin signalling during tumour progression. Nat Rev Mol Cell Biol 2004, 5:816-826.
101. Carey S.P., Charest J.M., Reinhart-King C.A. Forces during cell adhesion and spreading: implications for cellular homeostasis. Cellular and biomolecular mechanics and mechanobiology 2011, 29-69. Springer-Verlag, Berlin and Heidelberg. A. Gefen (Ed.).
102. Wheelock M.J., Shintani Y., Maeda M., Fukumoto Y., Johnson K.R. Cadherin switching. J Cell Sci 2008, 121:727-735.
103. Baranwal S., Alahari S.K. Molecular mechanisms controlling E-cadherin expression in breast cancer. Biochem Biophys Res Commun 2009, 384:6-11.
104. Gonzalez M., Pinder S., Wencyk P., Bell J., Elston C., Nicholson R., et al. An immunohistochemical examination of the expression of E-cadherin and alpha- and beta/gamma-catenins, and alpha2- and beta1-integrins in invasive breast cancer. J Pathol 1999, 187:523-529.
105. Cavallaro U., Christofori G. Cell adhesion in tumor invasion and metastasis: loss of the glue is not enough. Biochim Biophys Acta 2001, 1552:39-45.
106. Kleer C.G., van Golen K.L., Braun T., Merajver S.D. Persistent E-cadherin expression in inflammatory breast cancer. Mod Pathol 2001, 14:458-464.
107. Hiscox S., Jiang W.G. Ezrin regulates cell-cell and cell-matrix adhesion, a possible role with E-cadherin/beta-catenin. J Cell Sci 1999, 112:3081-3090.
108. Somasiri A., Nielsen J.S., Makretsov N., McCoy M.L., Prentice L., Gilks C.B., et al. Overexpression of the anti-adhesin podocalyxin is an independent predictor of breast cancer progression. Cancer Res 2004, 64:5068-5073.
109. White D.E., Kurpios N.A., Zuo D., Hassell J.A., Blaess S., Mueller U., et al. Targeted disruption of beta1-integrin in a transgenic mouse model of human breast cancer reveals an essential role in mammary tumor induction. Cancer Cell 2004, 6:159-170.
110. Balaban N.Q., Schwarz U.S., Riveline D., Goichberg P., Tzur G., Sabanay I., et al. Force and focal adhesion assembly: a close relationship studied using elastic micropatterned substrates. Nat Cell Biol 2001, 3:466-472.
111. Liu H., Radisky D.C., Wang F., Bissell M.J. Polarity and proliferation are controlled by distinct signaling pathways downstream of PI3-kinase in breast epithelial tumor cells. J Cell Biol 2004, 164:603-612.
112. Provenzano P.P., Inman D.R., Eliceiri K.W., Keely P.J. Matrix density-induced mechanoregulation of breast cell phenotype, signaling and gene expression through a FAK-ERK linkage. Oncogene 2009, 28:4326-4343.
113. Levental K.R., Yu H., Kass L., Lakins J.N., Egeblad M., Erler J.T., et al. Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell 2009, 139:891-906.
114. Clarke M., Spudich J.A. Nonmuscle contractile proteins: the role of actin and myosin in cell motility and shape determination. Annu Rev Biochem 1977, 46:797-822.
115. Totsukawa G., Yamakita Y., Yamashiro S., Hartshorne D.J., Sasaki Y., Matsumura F. Distinct roles of ROCK (Rho-kinase) and MLCK in spatial regulation of MLC phosphorylation for assembly of stress fibers and focal adhesions in 3T3 fibroblasts. J Cell Biol 2000, 150:797-806.
116. Amano M., Ito M., Kimura K., Fukata Y., Chihara K., Nakano T., et al. Phosphorylation and activation of myosin by Rho-associated kinase (Rho-kinase). J Biol Chem 1996, 271:20246-20249.
117. Kawano Y., Fukata Y., Oshiro N., Amano M., Nakamura T., Ito M., et al. Phosphorylation of myosin-binding subunit (MBS) of myosin phosphatase by Rho-kinase in vivo. J Cell Biol 1999, 147:1023-1037.
118. Vega F.M., Fruhwirth G., Ng T., Ridley A.J. RhoA and RhoC have distinct roles in migration and invasion by acting through different targets. J Cell Biol 2011, 193:655-665.
119. Fritz G., Just I., Kaina B. Rho GTPases are over-expressed in human tumors. Int J Cancer 1999, 81:682-687.
120. Sahai E., Marshall C.J. Rho-GTPases and cancer. Nat Rev Cancer 2002, 2:133-142.
121. Schlaepfer D.D., Hauck C.R., Sieg D.J. Signaling through focal adhesion kinase. Prog Biophys Mol Biol 1999, 71:435-478.
122. Klemke R.L., Cai S., Giannini A.L., Gallagher P.J., de Lanerolle P., Cheresh D.A. Regulation of cell motility by mitogen-activated protein kinase. J Cell Biol 1997, 137:481-492.
123. Webb D.J., Donais K., Whitmore L.A., Thomas S.M., Turner C.E., Parsons J.T., et al. FAK-Src signalling through paxillin, ERK and MLCK regulates adhesion disassembly. Nat Cell Biol 2004, 6:154-161.
124. Helfman D.M., Pawlak G. Myosin light chain kinase and acto-myosin contractility modulate activation of the ERK cascade downstream of oncogenic Ras. J Cell Biochem 2005, 95:1069-1080.
125. Bhadriraju K., Yang M., Ruiz S.A., Pirone D., Tan J., Chen C.S. Activation of ROCK by RhoA is regulated by cell adhesion, shape, and cytoskeletal tension. Exp Cell Res 2007, 313:3616-3623.
126. Wozniak M.A., Chen C.S. Mechanotransduction in development: a growing role for contractility. Nat Rev Mol Cell Biol 2009, 10:34-43.
127. Wozniak M.A., Desai R., Solski P.A., Der C.J., Keely P.J. ROCK-generated contractility regulates breast epithelial cell differentiation in response to the physical properties of a three-dimensional collagen matrix. J Cell Biol 2003, 163:583-595.
128. Polte T.R., Eichler G.S., Wang N., Ingber D.E. Extracellular matrix controls myosin light chain phosphorylation and cell contractility through modulation of cell shape and cytoskeletal prestress. Am J Physiol Cell Physiol 2004, 286:C518-C528.
129. Yeung T., Georges P.C., Flanagan L.A., Marg B., Ortiz M., Funaki M., et al. Effects of substrate stiffness on cell morphology, cytoskeletal structure, and adhesion. Cell Motil Cytoskeleton 2005, 60:24-34.
130. Giannone G., Sheetz M.P. Substrate rigidity and force define form through tyrosine phosphatase and kinase pathways. Trends Cell Biol 2006, 16:213-223.
131. Peyton S.R., Ghajar C.M., Khatiwala C.B., Putnam A.J. The emergence of ECM mechanics and cytoskeletal tension as important regulators of cell function. Cell Biochem Biophys 2007, 47(2):300-320.
132. Buxboim A., Ivanovska I.L., Discher D.E. Matrix elasticity, cytoskeletal forces and physics of the nucleus: how deeply do cells "feel" outside and in?. J Cell Sci 2010, 123:297-308.
133. Provenzano P.P., Keely P.J. Mechanical signaling through the cytoskeleton regulates cell proliferation by coordinated focal adhesion and Rho GTPase signaling. J Cell Sci 2011, 124:1195-1205.
134. Kraning-Rush C.M., Carey S.P., Califano J.P., Smith B.N., Reinhart-King C.A. The role of the cytoskeleton in cellular force generation in 2D and 3D environments. Phys Biol 2011, 8:015009.
135. Wang N., Ingber D.E. Control of cytoskeletal mechanics by extracellular matrix, cell shape, and mechanical tension. Biophys J 1994, 66:2181-2189.
136. Döbereiner H.-G., Dubin-Thaler B.J., Giannone G., Sheetz M.P. Force sensing and generation in cell phases: analyses of complex functions. J Appl Physiol 2005, 98:1542-1546.
137. Laevsky G., Knecht D.A. Cross-linking of actin filaments by myosin II is a major contributor to cortical integrity and cell motility in restrictive environments. J Cell Sci 2003, 116:3761-3770.
138. Fischer R.S., Gardel M., Ma X., Adelstein R.S., Waterman C.M. Local cortical tension by myosin II guides 3D endothelial cell branching. Curr Biol 2009, 19:260-265.
139. Wyckoff J.B., Pinner S.E., Gschmeissner S., Condeelis J.S., Sahai E. ROCK- and myosin-dependent matrix deformation enables protease-independent tumor-cell invasion in vivo. Curr Biol 2006, 16:1515-1523.
140. Guck J., Lautenschläger F., Paschke S., Beil M. Critical review: cellular mechanobiology and amoeboid migration. Integr Biol 2010, 2:575-583.
141. Dembo M., Wang Y.-L. Stresses at the cell-to-substrate interface during locomotion of fibroblasts. Biophys J 1999, 76:2307-2316.
142. Reinhart-King C.A., Dembo M., Hammer D.A. Endothelial cell traction forces on RGD-derivatized polyacrylamide substrata. Langmuir 2003, 19:1573-1579.
143. du Roure O., Saez A., Buguin A., Austin R.H., Chavrier P., Silberzan P., et al. Force mapping in epithelial cell migration. Proc Natl Acad Sci USA 2005, 102:2390-2395.
144. Califano J.P., Reinhart-King C.A. Substrate stiffness and cell area predict cellular traction stresses in single cells and cells in contact. Cell Mol Bioeng 2010, 3:68-75.
145. Gunzer M., Friedl P., Niggemann B., Brocker E.-B., Kampgen E., Zanker K.S. Migration of dendritic cells within 3-D collagen lattices is dependent on tissue origin, state of maturation, and matrix structure and is maintained by proinflammatory cytokines. J Leukocyte Biol 2000, 67:622-629.
146. Mierke C.T., Rösel D., Fabry B., Brábek J. Contractile forces in tumor cell migration. Eur J Cell Biol 2008, 87:669-676.
147. Meshel A.S., Wei Q., Adelstein R.S., Sheetz M.P. Basic mechanism of three-dimensional collagen fibre transport by fibroblasts. Nat Cell Biol 2005, 7:157-164.
148. Provenzano P.P., Inman D.R., Eliceiri K.W., Trier S.M., Keely P.J. Contact guidance mediated three-dimensional cell migration is regulated by Rho/ROCK-dependent matrix reorganization. Biophys J 2008, 95:5374-5384.
149. Petrie R.J., Doyle A.D., Yamada K.M. Random versus directionally persistent cell migration. Nat Rev Mol Cell Biol 2009, 10:538-549.
150. Poincloux R., Collin O., Lizárraga F., Romao M., Debray M., Piel M., et al. Contractility of the cell rear drives invasion of breast tumor cells in 3D Matrigel. Proc Natl Acad Sci USA 2011, 108:1943-1948.
151. Oliver T., Dembo M., Jacobson K. Separation of propulsive and adhesive traction stresses in locomoting keratocytes. J Cell Biol 1999, 145:589-604.
152. Tamariz E., Grinnell F. Modulation of fibroblast morphology and adhesion during collagen matrix remodeling. Mol Biol Cell 2002, 13:3915-3929.
153. Bloom R.J., George J.P., Celedon A., Sun S.X., Wirtz D. Mapping local matrix remodeling induced by a migrating tumor cell using three-dimensional multiple-particle tracking. Biophys J 2008, 95:4077-4088.
154. Shih W., Yamada S. Myosin IIA dependent retrograde flow drives 3D cell migration. Biophys J 2010, 98:L29-L31.
155. Legant W.R., Miller J.S., Blakely B.L., Cohen D.M., Genin G.M., Chen C.S. Measurement of mechanical tractions exerted by cells in three-dimensional matrices. Nat Methods 2010, 7:969-971.
156. Wolf K., Friedl P. Mapping proteolytic cancer cell-extracellular matrix interfaces. Clin Exp Metastasis 2009, 26:289-298.
157. Pizzo A.M., Kokini K., Vaughn L.C., Waisner B.Z., Voytik-Harbin S.L. Extracellular matrix (ECM) microstructural composition regulates local cell-ECM biomechanics and fundamental fibroblast behavior: a multidimensional perspective. J Appl Physiol 2005, 98:1909-1921.
158. Kim A., Lakshman N., Petroll W.M. Quantitative assessment of local collagen matrix remodeling in 3-D culture: the role of Rho kinase. Exp Cell Res 2006, 312:3683-3692.
159. Pang Y., Ucuzian A.A., Matsumura A., Brey E.M., Gassman A.A., Husak V.A., et al. The temporal and spatial dynamics of microscale collagen scaffold remodeling by smooth muscle cells. Biomaterials 2009, 30:2023-2031.
160. Wolf K., Mazo I., Leung H., Engelke K., von Andrian U.H., Deryugina E.I., et al. Compensation mechanism in tumor cell migration: mesenchymal-amoeboid transition after blocking of pericellular proteolysis. J Cell Biol 2003, 160:267-277.
161. Friedl P., Maaser K., Klein C.E., Niggemann B., Krohne G., Zänker K.S. Migration of highly aggressive MV3 melanoma cells in 3-dimensional collagen lattices results in local matrix reorganization and shedding of alpha2 and beta1 integrins and CD44. Cancer Res 1997, 57:2061-2070.
162. Hartmann A., Boukamp P., Friedl P. Confocal reflection imaging of 3D fibrin polymers. Blood Cell Mol Dis 2006, 36:191-193.
163. Petroll W.M., Cavanagh H.D., Jester J.V. Dynamic three-dimensional visualization of collagen matrix remodeling and cytoskeletal organization in living corneal fibroblasts. Scanning 2004, 26:1-10.
164. Vanni S., Lagerholm C., Otey C., Taylor D.L., Lanni F. Internet-based image analysis quantifies contractile behavior of individual fibroblasts inside model tissue. Biophys J 2003, 84:2715-2727.
165. Roeder B.A., Kokini K., Robinson J.P., Voytik-Harbin S.L. Local, three-dimensional strain measurements within largely deformed extracellular matrix constructs. J Biomech Eng - Trans ASME 2004, 126:699-708.
166. Ng C.P., Swartz M.A. Mechanisms of interstitial flow-induced remodeling of fibroblast-collagen cultures. Ann Biomed Eng 2006, 34:446-454.
167. Zaman M.H., Trapani L.M., Sieminski A.L., MacKellar D., Gong H., Kamm R.D., et al. Migration of tumor cells in 3D matrices is governed by matrix stiffness along with cell-matrix adhesion and proteolysis. Proc Natl Acad Sci USA 2006, 103:10889-10894.
168. Suresh S. Biomechanics and biophysics of cancer cells. Acta Biomater 2007, 3:413-438.
169. Bao G., Suresh S. Cell and molecular mechanics of biological materials. Nat Mater 2003, 2:715-725.
170. Fletcher D.A., Mullins R.D. Cell mechanics and the cytoskeleton. Nature 2010, 463:485-492.
171. Elson E.L. Cellular mechanics as an indicator of cytoskeletal structure and function. Annu Rev Biophys Biol 1988, 17:397-430.
172. Stamenović D., Coughlin M.F. The role of prestress and architecture of the cytoskeleton and deformability of cytoskeletal filaments in mechanics of adherent cells: a quantitative analysis. J Theor Biol 1999, 201:63-74.
173. Discher D.E., Janmey P., Wang Y.-L. Tissue cells feel and respond to the stiffness of their substrate. Science 2005, 310:1139-1143.
174. Baker E.L., Lu J., Yu D., Bonnecaze R.T., Zaman M.H. Cancer cell stiffness: integrated roles of three-dimensional matrix stiffness and transforming potential. Biophys J 2010, 99:2048-2057.
175. Sokolov I. Atomic force microscopy in cancer cell research. Cancer nanotechnology 2007, 1-17. American Scientific Publishers. H.S. Nalwa, T. Webster (Eds.).
176. Guck J., Schinkinger S., Lincoln B., Wottawah F., Ebert S., Romeyke M., et al. Optical deformability as an inherent cell marker for testing malignant transformation and metastatic competence. Biophys J 2005, 88:3689-3698.
177. Cross S.E., Jin Y.-S., Rao J., Gimzewski J.K. Nanomechanical analysis of cells from cancer patients. Nat Nanotechnol 2007, 2:780-783.
178. Ochalek T., Nordt F.J., Tullberg K., Burger M.M. Correlation between cell deformability and metastatic potential in B16-F1 melanoma cell variants. Cancer Res 1988, 48:5124-5128.
179. Lekka M., Laidler P., Gil D., Lekki J., Stachura Z., Hrynkiewicz A.Z. Elasticity of normal and cancerous human bladder cells studied by scanning force microscopy. Eur Biophys J 1999, 28:312-316.
180. Beil M., Micoulet A., von Wichert G., Paschke S., Walther P., Omary M.B., et al. Sphingosylphosphorylcholine regulates keratin network architecture and visco-elastic properties of human cancer cells. Nat Cell Biol 2003, 5:803-811.
181. Swaminathan V., Mythreye K., O'Brien E.T., Berchuck A., Blobe G.C., Superfine R. Mechanical stiffness grades metastatic potential in patient tumor cells and in cancer cell lines. Cancer Res 2011, 71:5075-5080.
182. Rosenbluth M.J., Lam W.A., Fletcher D.A. Force microscopy of nonadherent cells: a comparison of leukemia cell deformability. Biophys J 2006, 90:2994-3003.
183. Farina K.L., Wyckoff J.B., Rivera J., Lee H., Segall J.E., Condeelis J.S., et al. Cell motility of tumor cells visualized in living intact primary tumors using green fluorescent protein. Cancer Res 1998, 58:2528-2532.
184. Wolf K., Müller R., Borgmann S., Bröcker E.-B., Friedl P. Amoeboid shape change and contact guidance: T-lymphocyte crawling through fibrillar collagen is independent of matrix remodeling by MMPs and other proteases. Blood 2003, 102:3262-3269.
185. Wolf K., Wu Y.I., Liu Y., Geiger J., Tam E., Overall C., et al. Multi-step pericellular proteolysis controls the transition from individual to collective cancer cell invasion. Nat Cell Biol 2007, 9:893-904.
186. Guilak F., Tedrow J.R., Burgkart R. Viscoelastic properties of the cell nucleus. Biochem Biophys Res Commun 2000, 269:781-786.
187. Friedl P., Wolf K., Lammerding J. Nuclear mechanics during cell migration. Curr Opin Cell Biol 2011, 23:55-64.
188. Croft D.R., Sahai E., Mavria G., Li S., Tsai J., Lee W.M.F., et al. Conditional ROCK activation in vivo induces tumor cell dissemination and angiogenesis. Cancer Res 2004, 64:8994-9001.
189. Rösel D., Brábek J., Tolde O., Mierke C.T., Zitterbart D.P., Raupach C., et al. Up-regulation of Rho/ROCK signaling in sarcoma cells drives invasion and increased generation of protrusive forces. Mol Cancer Res 2008, 6:1410-1420.
190. Panková K., Rösel D., Novotný M., Brábek J. The molecular mechanisms of transition between mesenchymal and amoeboid invasiveness in tumor cells. Cell Mol Life Sci 2010, 67:63-71.